ESR1 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is characterized by the lack of three key molecular signatures: estrogen receptor (ER) expression, progesterone receptor (PR) expression, and HER2 overexpression; it comprises approximately 15% of all invasive breast cancers [1].